A potentially immunologically inert derivative of the reverse tetracycline-controlled transactivator.

A. Zalmbumbide, S. Weening, S.J. Cramer, M.J. Rabelink, J. Verhaagen, R.C. Hoeben

Research output: Contribution to journal/periodicalArticleScientificpeer-review

Original languageEnglish
Pages (from-to)749-754
JournalBiotechnology Letters
Volume32
DOIs
Publication statusPublished - 2010

Cite this